UNSPSC 51173233: Potassium bitartrate/sodium bicarbonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RS300. This VA Drug Class (RS300) classifies this compound as belonging to the group LAXATIVES, RECTAL.

UNSPSC 51173233 Potassium bitartrate/sodium bicarbonate is a Commodity code that in recent state and local procurement activity covers drug testing reagents and screening supplies used in offender specimen collection and testing programs. State and local governments solicit under this code for the chemical reagents, testing kits, and consumables required to conduct immunoassay screening, confirmatory testing via LC/MS/MS or GC/MS, and alternative testing methodologies including oral fluid and hair analysis in community supervision and corrections contexts. Issuing bodies include county community supervision and corrections departments managing offender drug testing programs; the code appears to see limited but specialized activity concentrated in jurisdictions with active criminal justice community supervision operations.

Collin County Community Supervision and Corrections Department in Texas posted RFP 2026-327 for offender specimen collection and drug testing services on September 25, 2026, with proposals due July 23, 2026 at 2:00 p.m. The scope encompasses staffing two collection sites in Plano and McKinney and operation of testing methodologies requiring lab-certified reagents and screening supplies; the county anticipates approximately 25,031 tests annually comprising five-panel and six-panel screens with confirmatory analysis. The estimated contract value is $600,000 over a two-year initial term with three optional one-year renewals. Funding derives from Texas Department of Criminal Justice-Community Justice Assistance Division appropriations. The county may award in whole or in part to multiple vendors, with evaluation weighted on vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), plus optional Phase 2 demonstrations (up to 30 points). The anticipated award date is August 10, 2026.